eMedicine Specialties > Emergency Medicine > Endocrine & Metabolic
Hypermagnesemia
Updated: Jan 22, 2010
Introduction
Background
Magnesium is one of the body's major electrolytes. As the second most common intracellular cation, it plays a vital role in many cellular metabolic pathways.1 Magnesium is required for deoxyribonucleic acid (DNA) and protein synthesis. It is a necessary cofactor for most enzymes in phosphorylation reactions. It is also important for parathyroid hormone synthesis.
The total body content of this central cation is 2000 mEq, or 24 g. The magnesium is distributed in bone (67%), intracellularly (31%), and extracellularly (a mere 1%).2 The intracellular concentration is 40 mEq/L, while the normal serum concentration is 1.5-2.0 mEq/L. Of this serum component, 25-30% is protein bound, 10-15% is complexed, and the remaining 50-60% is ionized.
Magnesium is absorbed in the ileum and excreted in stool and urine. The minimum daily requirement of magnesium is 300-350 mg, or 15 mmol; this amount is easily obtainable with a normal daily intake of fruits, seeds, and vegetables because magnesium is a component of chlorophyll and is present in high concentrations in all green plants.
The kidney is the main regulator of magnesium concentrations. Absorption occurs primarily in the proximal tubule and thick ascending limb of the loop of Henle.
Hypermagnesemia is a rare electrolyte abnormality because the kidney is very effective in excreting excess magnesium.3
Pathophysiology
Magnesium excess affects the CNS, neuromuscular, and cardiac organ systems. It most commonly is observed in renal insufficiency and in patients receiving intravenous (IV) magnesium for treatment of a medical condition.4
Frequency
United States
Hypermagnesemia occurs only rarely in the United States.
Clinical
History
Common causes of hypermagnesemia include renal failure and iatrogenic manipulations. However, other diseases may result in increased magnesium; the degree of elevation determines the symptoms. Acute elevations of magnesium usually are more symptomatic than slow rises.
- Magnesium levels of 2-4 mEq/L are associated with the following:
- Nausea
- Vomiting
- Skin flushing
- Weakness
- Lightheadedness
- High magnesium levels are associated with depressed levels of consciousness, respiratory depression, and cardiac arrest.
Physical
Physical findings are related to the serum magnesium levels.
- Serum magnesium levels of 3.5-5.0 mEq/L are associated with the following:
- Disappearance of deep tendon reflexes
- Muscle weakness
- Serum magnesium levels of 5.0-6.0 mEq/L are related to the following:
- Hypotension
- Vasodilatation
- Serum magnesium levels of 8.0-10.0 mEq/L are associated with the following:
- Arrhythmia, including atrial fibrillation
- Intraventricular conduction delay
- Flaccid skeletal muscle paralysis
- Levels of serum magnesium greater than 10.0 mEq/L are related to the following:
- Asystole
- Heart block
- Ventilatory failure
- Stupor or coma
- Death
- Elevated levels of magnesium also are associated with the following:
- Delayed thrombin formation
- Platelet clumping
Causes
Most cases of hypermagnesemia are due to iatrogenic interventions and administration,1 especially errors in calculating appropriate infusions. Additional causes include the following:
- Ingestion of magnesium-containing substances such as vitamins, antacids, or cathartics by patients with chronic renal failure
- Acute renal failure (in the absence of dialysis)
- Excessive intravenous infusions of magnesium in patients being treated for eclampsia, asthma, torsade de pointes, or other cardiac arrhythmias
- In neonates, treatment of maternal eclampsia with magnesium, which passes through the placental circulation
- Decreased GI elimination and increased GI absorption of magnesium due to intestinal hypomotility from any cause
- GI medications that decrease motility, including narcotics and anticholinergics
- Hypomotility disorders such as bowel obstruction and chronic constipation
- Tumor lysis syndrome, by releasing massive amounts of intracellular magnesium
- Adrenal insufficiency (secondary hypermagnesemia)
- Rhabdomyolysis, like tumor lysis syndrome, by releasing significant amounts of intracellular magnesium
- Milk-alkali syndrome
- Hypothyroidism
- Hypoparathyroidism
- Neoplasm with skeletal muscle involvement
- Lithium intoxication
- Extracellular volume contraction, as in diabetic ketoacidosis (DKA)
More on Hypermagnesemia |
Overview: Hypermagnesemia |
| Differential Diagnoses & Workup: Hypermagnesemia |
| Treatment & Medication: Hypermagnesemia |
| Follow-up: Hypermagnesemia |
| References |
| Next Page » |
References
Soave PM, Conti G, Costa R, Arcangeli A. Magnesium and anaesthesia. Curr Drug Targets. Aug 2009;10(8):734-43. [Medline].
Kaze Folefack F, Stoermann Chopard C. [Magnesium metabolism disturbances]. Rev Med Suisse. Mar 7 2007;3(101):605-6, 608, 610-1. [Medline].
Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol. 2009;41(2):357-62. [Medline].
Guillaume T, Krzesinski JM. [Management of serum magnesium abnormalities]. Rev Med Liege. Jul-Aug 2003;58(7-8):465-7. [Medline].
Agus ZS, Wasserstein A, Goldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med. Mar 1982;72(3):473-88. [Medline].
Birrer RB, Shallash AJ, Totten V. Hypermagnesemia-induced fatality following epsom salt gargles(1). J Emerg Med. Feb 2002;22(2):185-8. [Medline].
Gigg MA, Wolfson AB, Tayal VS. Electrolyte disturbances. In: Emergency Medicine Concepts and Clinical Practice. Vol 3. 1998:2445-8.
Knochel JP. Disorders of magnesium metabolism. In: Harrison's Principles of Internal Medicine. Vol 2. 1994:2187-9.
Londner M, Hammer D, Kelen G. Fluid and electrolyte problems. In: Emergency Medicine Comprehensive Study Guide. 2004:177-178.
Moe SM. Disorders of calcium, phosphorus, and magnesium. Am J Kidney Dis. Jan 2005;45(1):213-8. [Medline].
Nadler JL, Rude RK. Disorders of magnesium metabolism. In: Clinical Disorders of Fluid and Electrolyte Metabolism. Vol 24. 1995:623-37.
Qureshi T, Melonakos TK. Acute hypermagnesemia after laxative use. Ann Emerg Med. Nov 1996;28(5):552-5. [Medline].
Usowicz MM, Gigg M, Jones LM. Allosteric interactions at L-type calcium channels between FPL 64176 and the enantiomers of the dihydropyridine Bay K 8644. J Pharmacol Exp Ther. Nov 1995;275(2):638-45. [Medline].
Wilson RF, Barton C. Fluid and electrolyte problems. In: Emergency Medicine Comprehensive Study Guide. 1996:135-7.
Further Reading
Keywords
hypermagnesemia, high magnesium level, hypermagnesemia treatment, hypermagnesemia causes, hypermagnesemia symptoms, magnesium absorption, excess magnesium, renal insufficiency, magnesium toxicity
Overview: Hypermagnesemia